LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain malignancy known for its fast growth and unresponsiveness to standard treatments. Investigations are constantly underway to identify new treatment strategies, and recently, a new biomarker named LCA168 has emerged as a potential avenue for glioblastoma treatment. LCA168 is a protein that is highly expressed in GB